Vækstfonden Life Science Ventures

EIFO (Export and Investment Fund of Denmark), formerly known in the venture space as Vækstfonden Life Science Ventures, is the Danish state's sovereign investment fund. The organization provides venture capital, loans, and guarantees to Danish companies, with a dedicated team focused on the life sciences sector. Its life science investment strategy targets early-stage and clinical-stage companies in biotechnology, medtech, and digital health that demonstrate significant global potential. By acting as a cornerstone investor, EIFO helps bridge the funding gap for innovative startups, often co-investing with private venture capital firms and institutional investors. The fund's portfolio includes a wide range of therapeutic areas, including oncology, neurology, and rare diseases. EIFO plays a critical role in the Danish life science ecosystem by supporting the transition of academic research into commercially viable healthcare solutions.